Surface-guided radiotherapy imaging and safety systems for cancer treatment
Vision RT develops computer-vision and AI-based systems to monitor and guide radiotherapy delivery, operating deep in the medical devices and oncology stack with a focus on treatment accuracy and patient safety. The tech stack is tightly specialized—C, C++, VHDL, Windows OS—reflecting embedded medical-device constraints rather than modern cloud infrastructure. Hiring is accelerating across engineering (7 open roles) and support (6), with active clinical testing and post-market surveillance projects signaling a company scaling regulatory oversight and clinical adoption alongside product development.
Vision RT, founded in 2001 and headquartered in London, invented Surface Guided Radiation Therapy (SGRT), a computer-vision-based approach to real-time patient positioning and treatment monitoring during radiotherapy. The company sells to radiation oncology departments and cancer treatment centers, helping clinicians ensure that treatment beams reach target tumors while minimizing exposure to healthy tissue. With 201–500 employees across engineering, clinical, support, and manufacturing, Vision RT operates a vertically integrated business: designing safety-critical imaging hardware (VHDL, embedded C), managing regulatory compliance and post-market surveillance, and supporting clinical adoption of new releases across global markets.
Vision RT uses C, C++, VHDL, and Windows-based software to build real-time imaging and positioning systems. The stack reflects embedded medical-device design constraints rather than general-purpose platforms.
Vision RT is recruiting across the United Kingdom, United States, France, Germany, and Netherlands, signaling a multi-region expansion strategy.
Other companies in the same industry, closest in size